Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2021

Open Access 01-12-2021 | Multiple Myeloma | Case report

Eosinophilic fasciitis (Shulman syndrome), a rare entity and diagnostic challenge, as a manifestation of severe chronic graft-versus-host disease: a case report

Authors: Thomas Chalopin, Nicolas Vallet, Marion Morel, Raphael Maguet, Louis d’Alteroche, Gonzague de Pinieux, Olivier Hérault, Emmanuel Gyan, Laurent Sutton, Alban Villate

Published in: Journal of Medical Case Reports | Issue 1/2021

Login to get access

Abstract

Background

Shulman’s disease, or eosinophilic fasciitis (EF), is a rare autoimmune disease, characterized by sclerodermic skin lesions with progressive induration and thickening of the soft tissues. Chronic graft-versus-host-disease (GVHD) presenting as EF is a very rare manifestation of cutaneous GVHD.

Case presentation

We report an unusual case of EF in a 46-year-old Caucasian male patient who had received an allogenic hematopoietic stem cell transplantation in the context of relapsed/refractory multiple myeloma. The diagnosis was challenging, with the patient presenting hepatic dysfunction, normal eosinophils count, and incomplete clinical signs. Magnetic resonance imaging (MRI) and skin biopsy confirmed the diagnosis of EF. Early initiation of specific treatment with corticosteroids and prednisolone achieved complete response.

Conclusion

In practice, incomplete signs in this rare complication should lead to MRI as it is a major tool to guide decision-making based on the skin biopsy, allowing a rapid diagnosis and the initiation of treatment without delay.
Literature
1.
go back to reference Fett N, Arthur M. Eosinophilic fasciitis: current concepts. Clin Dermatol. 2018;36(4):487–97.CrossRef Fett N, Arthur M. Eosinophilic fasciitis: current concepts. Clin Dermatol. 2018;36(4):487–97.CrossRef
2.
go back to reference Pinal-Fernandez I, Selva-O’ Callaghan A, Grau JM. Diagnosis and classification of eosinophilic fasciitis. Autoimmun Rev. 2014;13:379–82.CrossRef Pinal-Fernandez I, Selva-O’ Callaghan A, Grau JM. Diagnosis and classification of eosinophilic fasciitis. Autoimmun Rev. 2014;13:379–82.CrossRef
3.
go back to reference Lebeaux D, Frances C, Barete S, et al. Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients. Rheumatology. 2012;51:557–61.CrossRef Lebeaux D, Frances C, Barete S, et al. Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients. Rheumatology. 2012;51:557–61.CrossRef
4.
go back to reference Nashel J, Steen V. The use of an elevated aldolase in diagnosing and managing eosinophilic fasciitis. Clin Rheumatol. 2015;34:1481–4.CrossRef Nashel J, Steen V. The use of an elevated aldolase in diagnosing and managing eosinophilic fasciitis. Clin Rheumatol. 2015;34:1481–4.CrossRef
5.
go back to reference Cowen EW. Decoding skin involvement in chronic graft-vs-host disease. JAMA Dermatol. 2019;155(7):777–8. Cowen EW. Decoding skin involvement in chronic graft-vs-host disease. JAMA Dermatol. 2019;155(7):777–8.
6.
go back to reference Oda K, Nakaseko C, Ozawa S, et al. Fascitis and myositis: an analysis of muscle related complications caused by chronic GVHD after allo-SCT. Kanto Study Group for Cell Therapy (KSGCT). Bone Marrow Transplant. 2009;43:159–67.CrossRef Oda K, Nakaseko C, Ozawa S, et al. Fascitis and myositis: an analysis of muscle related complications caused by chronic GVHD after allo-SCT. Kanto Study Group for Cell Therapy (KSGCT). Bone Marrow Transplant. 2009;43:159–67.CrossRef
7.
go back to reference Ganta C, Chatterjee S, Pohlman B, et al. Chronic graft-versus-host disease presenting as eosinophilic fasciitis: therapeutic challenges and an additional case. J Clin Rheumatol. 2015;21:86–94.CrossRef Ganta C, Chatterjee S, Pohlman B, et al. Chronic graft-versus-host disease presenting as eosinophilic fasciitis: therapeutic challenges and an additional case. J Clin Rheumatol. 2015;21:86–94.CrossRef
8.
go back to reference Toquet C, Hamidou MA, Renaudin K, et al. In situ immunophenotype of the inflammatory infiltrate in eosinophilic fasciitis. J Rheumatol. 2003;30:1811–5.PubMed Toquet C, Hamidou MA, Renaudin K, et al. In situ immunophenotype of the inflammatory infiltrate in eosinophilic fasciitis. J Rheumatol. 2003;30:1811–5.PubMed
9.
go back to reference Moy AP, Maryamchik E, Nikolskaia OV, Nazarian RM. Th1- and Th17-polarized immune infiltrates in eosinophilic fasciitis—a potential marker for histopathologic distinction from morphea. J Cutan Pathol. 2017;44:548–52.CrossRef Moy AP, Maryamchik E, Nikolskaia OV, Nazarian RM. Th1- and Th17-polarized immune infiltrates in eosinophilic fasciitis—a potential marker for histopathologic distinction from morphea. J Cutan Pathol. 2017;44:548–52.CrossRef
10.
go back to reference Kumar S, Paiva B, Anderson KC, et al. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol. 2016;17(8):e328–46.CrossRef Kumar S, Paiva B, Anderson KC, et al. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol. 2016;17(8):e328–46.CrossRef
11.
go back to reference Desvignes-Engelbert A, Sauliere N, Loeuille D, et al. From diagnosis to remission: place of MRI in eosinophilic fasciitis. Clin Rheumatol. 2010;29:1461–4.CrossRef Desvignes-Engelbert A, Sauliere N, Loeuille D, et al. From diagnosis to remission: place of MRI in eosinophilic fasciitis. Clin Rheumatol. 2010;29:1461–4.CrossRef
12.
go back to reference Kirchgesner T, Dallaudière B, Omoumi P, et al. Eosinophilic fasciitis: typical abdnormalities, variants and differential diagnosis of fasciae abnormalities using MR imaging. Diagn Interv Imaging. 2016;97:79–86.CrossRef Kirchgesner T, Dallaudière B, Omoumi P, et al. Eosinophilic fasciitis: typical abdnormalities, variants and differential diagnosis of fasciae abnormalities using MR imaging. Diagn Interv Imaging. 2016;97:79–86.CrossRef
13.
go back to reference Sarantopoulos S, Cardones A, Sullivan K. How I treat refractory chronic graft-versus-host disease. Blood. 2019;133(11):1191–200.CrossRef Sarantopoulos S, Cardones A, Sullivan K. How I treat refractory chronic graft-versus-host disease. Blood. 2019;133(11):1191–200.CrossRef
14.
go back to reference Berianu F, Cohen MD, Abril A, Ginsburg WW. Eosinophilic fasciitis: clinical characteristics and response to methotrexate. Int J Rheum Dis. 2015;18:91–8.CrossRef Berianu F, Cohen MD, Abril A, Ginsburg WW. Eosinophilic fasciitis: clinical characteristics and response to methotrexate. Int J Rheum Dis. 2015;18:91–8.CrossRef
15.
go back to reference Bukiej A, Dropinski J, Dyduch G, Szczeklik A. Eosinophilic fasciitis successfully treated with cyclosporine. Clin Rheumatol. 2005;24:634–6.CrossRef Bukiej A, Dropinski J, Dyduch G, Szczeklik A. Eosinophilic fasciitis successfully treated with cyclosporine. Clin Rheumatol. 2005;24:634–6.CrossRef
16.
go back to reference Romano C, Rubegni P, De Aloe G, et al. Extracorporeal photochemotherapy in the treatment of eosinophilic fasciitis. J EurAcadDermatolVenereol. 2003;17:10–3. Romano C, Rubegni P, De Aloe G, et al. Extracorporeal photochemotherapy in the treatment of eosinophilic fasciitis. J EurAcadDermatolVenereol. 2003;17:10–3.
Metadata
Title
Eosinophilic fasciitis (Shulman syndrome), a rare entity and diagnostic challenge, as a manifestation of severe chronic graft-versus-host disease: a case report
Authors
Thomas Chalopin
Nicolas Vallet
Marion Morel
Raphael Maguet
Louis d’Alteroche
Gonzague de Pinieux
Olivier Hérault
Emmanuel Gyan
Laurent Sutton
Alban Villate
Publication date
01-12-2021

Other articles of this Issue 1/2021

Journal of Medical Case Reports 1/2021 Go to the issue